Jin Medical International Ltd. (ZJYL) director files insider ownership statement
Rhea-AI Filing Summary
Jin Medical International Ltd. reported insider information for director Xue Ning through an initial beneficial ownership statement. The report identifies Ning as a director of Jin Medical but does not list any non-derivative or derivative equity holdings or any insider transactions in the company’s securities as of this filing.
Positive
- None.
Negative
- None.
Key Terms
beneficial ownership, Rule 10b5-1 trading plans, derivative positions
3 terms
beneficial ownership financial
"file an initial statement of beneficial ownership of securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Rule 10b5-1 trading plans regulatory
"Footnotes may reference Rule 10b5-1 trading plans or pre-arranged"
Rule 10b5-1 trading plans are written, pre-arranged instructions that allow company insiders (such as executives or directors) to automatically buy or sell their company's stock at specified times or under set conditions, like a standing instruction or automated thermostat for trades. They matter to investors because these plans provide a legal defense against insider‑trading accusations and create predictable insider trading patterns that can help signal whether sales are routine portfolio management or potentially meaningful to the company’s outlook.
derivative positions financial
"derivativeSummary contains remaining derivative positions (unexercised options, warrants)"
Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Jin Medical International (ZJYL) disclose about Xue Ning in this Form 3?
Jin Medical International discloses that Xue Ning is a director of the company. The Form 3 does not report any non-derivative or derivative equity holdings or insider transactions for Ning in Jin Medical securities.
Does the Jin Medical International (ZJYL) Form 3 show any recent insider trades by Xue Ning?
The Form 3 shows no insider trades by Xue Ning. All transaction counters, including buys, sells, exercises, gifts, and tax withholdings, are zero, indicating no reportable transactions in this statement.
What role does reporting person Xue Ning hold at Jin Medical International (ZJYL)?
Reporting person Xue Ning is identified as a director of Jin Medical International Ltd. The filing does not indicate that Ning is an officer or a ten percent owner of the company.
Does the Jin Medical International (ZJYL) Form 3 include any derivative securities for Xue Ning?
No derivative securities are listed for Xue Ning in this Form 3. The derivativeSummary section is empty, and the filing reports zero derivative transactions or remaining derivative positions.